FRIDAY, May 12, 2023 (HealthDay News) — Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions. Although most of the Pulmonary-Allergy Drugs Advisory Committee members supported the spray for adults (16:6) and children (17:5),Continue Reading

WEDNESDAY, April 19, 2023 (HealthDay News) — Summer is almost here, and its arrival brings opportunities for many people – including those who suffer with allergies and asthma — to plan vacations away from home. A recent article titled “Allergies don’t take a vacation” in Annals of Allergy, Asthma &Continue Reading